Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive perspective. Supporters often stress the opportunity for substantial therapeutic outcomes, particularly in ailments where conventional medications have proven limited. However, crucially important to assess the substantial financial expenditure associated with CPI